HIF2a inhibitors for the treatment of VHL disease

por Metelo, Ana Martins, Noonan, Haley, Iliopoulos, Othon
Publicado 2015

Comparative Studies of the Proteome, Glycoproteome, and N-Glycome of Clear Cell Renal Cell Carcinoma Plasma before and after Curative Nephrectomy

por Gbormittah, Francisca O., Lee, Ling Y., Taylor, KyOnese, Hancock, William S., Iliopoulos, Othon
Publicado 2014

Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma

por Noonan, Haley R., Metelo, Ana M., Kamei, Caramai N., Peterson, Randall T., Drummond, Iain A., Iliopoulos, Othon
Publicado 2016

Metabolic requirements for cancer cell proliferation

por Keibler, Mark A., Wasylenko, Thomas M., Kelleher, Joanne K., Iliopoulos, Othon, Vander Heiden, Matthew G., Stephanopoulos, Gregory
Publicado 2016

Human Folliculin Delays Cell Cycle Progression through Late S and G2/M-Phases: Effect of Phosphorylation and Tumor Associated Mutations

por Laviolette, Laura A., Wilson, Jonas, Koller, Julia, Neil, Christopher, Hulick, Peter, Rejtar, Tomas, Karger, Barry, Teh, Bin Tean, Iliopoulos, Othon
Publicado 2013

Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL

por Arevalo, Aileen, Patel, Neal, Muraki, Peter, Ohtake, Shinji, Bratslavsky, Gennady, Clark, Chandra, Mann, Joshua, Iliopoulos, Othon, Jonasch, Eric, Srinivasan, Ramaprasad, Shuch, Brian
Publicado 2022

Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein

por Laviolette, Laura A., Mermoud, Julien, Calvo, Isabel A., Olson, Nicholas, Boukhali, Myriam, Steinlein, Ortrud K., Roider, Elisabeth, Sattler, Elke C., Huang, Dachuan, Teh, Bin Tean, Motamedi, Mo, Haas, Wilhelm, Iliopoulos, Othon
Publicado 2017

SYST-18 BELZUTIFAN TREATMENT FOR PATIENTS WITH VON HIPPEL-LINDAU DISEASE–ASSOCIATED CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMAS ENROLLED IN THE PHASE 2 LITESPARK-004 STUDY

por Narayan, Vivek, Iliopoulos, Othon, Iversen, Ane B, Maughan, Benjamin L, Beckermann, Kathryn E, Oudard, Stephane, Else, Tobias, Maranchie, Jodi K, Fu, Wei, Perini, Rodolfo F, Liu, Yanfang, Linehan, W Marston, Srinivasan, Ramaprasad, Jonasch, Eric
Publicado 2023

The fission yeast FLCN/FNIP complex augments TORC1 repression or activation in response to amino acid (AA) availability

por Calvo, Isabel A., Sharma, Shalini, Paulo, Joao A., Gulka, Alexander O.D., Boeszoermenyi, Andras, Zhang, Jingyu, Lombana, Jose M., Palmieri, Christina M., Laviolette, Laura A., Arthanari, Haribabu, Iliopoulos, Othon, Gygi, Steven P., Motamedi, Mo
Publicado 2021

Hypoxia drives transient site-specific copy gain and drug-resistant gene expression

por Black, Joshua C., Atabakhsh, Elnaz, Kim, Jaegil, Biette, Kelly M., Van Rechem, Capucine, Ladd, Brendon, Burrowes, Paul d., Donado, Carlos, Mattoo, Hamid, Kleinstiver, Benjamin P., Song, Bing, Andriani, Grasiella, Joung, J. Keith, Iliopoulos, Othon, Montagna, Cristina, Pillai, Shiv, Getz, Gad, Whetstine, Johnathan R.
Publicado 2015

Seventh BHD international symposium: recent scientific and clinical advancement

por Woodford, Mark R., Andreou, Avgi, Baba, Masaya, van de Beek, Irma, Di Malta, Chiara, Glykofridis, Iris, Grimes, Hannah, Henske, Elizabeth P., Iliopoulos, Othon, Kurihara, Masatoshi, Lazor, Romain, Linehan, W. Marston, Matsumoto, Kenki, Marciniak, Stefan J., Namba, Yukiko, Pause, Arnim, Rajan, Neil, Ray, Anindita, Schmidt, Laura S., Shi, Wei, Steinlein, Ortrud K., Thierauf, Julia, Zoncu, Roberto, Webb, Anna, Mollapour, Mehdi
Publicado 2022